...
首页> 外文期刊>Endoscopy International Open >Radiation exposure dose of fluoroscopy-guided gastrointestinal procedures: A single-center retrospective study
【24h】

Radiation exposure dose of fluoroscopy-guided gastrointestinal procedures: A single-center retrospective study

机译:辐射曝光剂量的透视引导胃肠手术:单中心回顾性研究

获取原文
           

摘要

Abstract Background and study aims?Fluoroscopy-guided gastrointestinal procedures (FGPs) are increasingly common. However, the radiation exposure (RE) to patients undergoing FGPs is still unclear. We examined the actual RE of FGPs. Patients and methods?This retrospective, single-center cohort study included consecutive FGPs, including endoscopic retrograde cholangiopancreatography (ERCP), interventional endoscopic ultrasound (EUS), enteral stenting, balloon-assisted enteroscopy, tube placement, endoscopic injection sclerotherapy (EIS), esophageal balloon dilatation and repositioning for sigmoid volvulus, from September 2012 to June 2019. We measured the air kerma (AK, mGy), dose area product (DAP, Gycm2), and fluoroscopy time (FT, min) for each procedure. Results?In total, 3831 patients were enrolled. Overall, 2778 ERCPs were performed. The median AK, DAP, and FT were as follows: ERCP: 109?mGy, 13.3?Gycm2 and 10.0?min; self-expandable enteral stenting (SEMS): 62?mGy, 12.4?Gycm2 and 10.4?min; tube placement: 40?mGy, 13.8?Gycm2 and 11.1 min; balloon-assisted enteroscopy: 43?mGy, 22.4?Gycm2 and 18.2?min; EUS cyst drainage (EUS-CD): 96?mGy, 18.3?Gycm2 and 10.4?min; EIS: 36?mGy, 8.1?Gycm2 and 4.4?min; esophageal balloon dilatation: 9?mGy, 2.2?Gycm2 and 1.8?min; and repositioning for sigmoid volvulus: 7?mGy, 4.7?Gycm2 and 1.6?min. Conclusion?This large series reporting actual RE doses of various FGPs could serve as a reference for future prospective studies.
机译:抽象背景和研究旨在?透视导向胃肠手术(FGP)越来越普遍。然而,辐射暴露(RE)给接受FGP的患者仍然不清楚。我们检查了FGP的实际RE。患者和方法?这种回顾性,单中心队列研究包括连续FGP,包括内窥镜逆行胆管痴呆症(ERCP),介入内窥镜超声(EUS),肠内支架,气球辅助肠镜检查,管置,内窥镜注射疗法(EIS),食管2012年9月至2019年6月,乙型葡萄球卷的球囊扩张和重新定位。我们测量了每种程序的空气Kerma(Ak,Mgy),剂量区域产品(DAP,GYCM2)和透视时间(FT,MIN)。结果?总共有3831名患者注册。总的来说,进行了2778个ERCP。中位数AK,DAP和FT如下:ERCP:109?MGY,13.3?GYCM2和10.0?min;自膨胀肠内支架(SEM):62?MGY,12.4?GYCM2和10.4?min;管置:40?MGY,13.8?GYCM2和11.1分钟;气球辅助肠镜检查:43?MGY,22.4?GYCM2和18.2?min; EUS囊肿排水(EUS-CD):96?MGY,18.3?GYCM2和10.4?min; EIS:36?MGY,8.1?GYCM2和4.4?min;食管球囊扩张:9?MGY,2.2?GYCM2和1.8?min;并重新定位Sigmoid Volvulus:7?MGY,4.7?GYCM2和1.6?min。结论?这个大型系列报告的各种FGPS的实际重复剂量可以作为未来前瞻性研究的参考。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号